These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33230552)

  • 1. Immunoglobulin G of systemic sclerosis patients programs a pro-inflammatory and profibrotic phenotype in monocyte-like THP-1 cells.
    Murthy S; Wannick M; Eleftheriadis G; Müller A; Luo J; Busch H; Dalmann A; Riemekasten G; Sadik CD
    Rheumatology (Oxford); 2021 Jun; 60(6):3012-3022. PubMed ID: 33230552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients.
    Günther J; Kill A; Becker MO; Heidecke H; Rademacher J; Siegert E; Radić M; Burmester GR; Dragun D; Riemekasten G
    Arthritis Res Ther; 2014 Mar; 16(2):R65. PubMed ID: 24612997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
    Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
    Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.
    van Lieshout AW; Vonk MC; Bredie SJ; Joosten LB; Netea MG; van Riel PL; Lafyatis R; van den Hoogen FH; Radstake TR
    Scand J Rheumatol; 2009; 38(4):282-90. PubMed ID: 19255934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis.
    Kill A; Tabeling C; Undeutsch R; Kühl AA; Günther J; Radic M; Becker MO; Heidecke H; Worm M; Witzenrath M; Burmester GR; Dragun D; Riemekasten G
    Arthritis Res Ther; 2014 Jan; 16(1):R29. PubMed ID: 24472528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4.
    Fineschi S; Goffin L; Rezzonico R; Cozzi F; Dayer JM; Meroni PL; Chizzolini C
    Arthritis Rheum; 2008 Dec; 58(12):3913-23. PubMed ID: 19035500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocytic Angiotensin and Endothelin Receptor Imbalance Modulate Secretion of the Profibrotic Chemokine Ligand 18.
    Rademacher J; Kill A; Mattat K; Dragun D; Siegert E; Günther J; Riemekasten G
    J Rheumatol; 2016 Mar; 43(3):587-91. PubMed ID: 26773103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis immunoglobulin induces growth and a pro-fibrotic state in vascular smooth muscle cells through the epidermal growth factor receptor.
    Arts MR; Baron M; Chokr N; Fritzler MJ; ; Servant MJ
    PLoS One; 2014; 9(6):e100035. PubMed ID: 24927197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
    Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
    Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies from Patients with Scleroderma Renal Crisis Promote PAR-1 Receptor Activation and IL-6 Production in Endothelial Cells.
    Simon M; Lücht C; Hosp I; Zhao H; Wu D; Heidecke H; Witowski J; Budde K; Riemekasten G; Catar R
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional autoantibodies in systemic sclerosis pathogenesis.
    Kill A; Riemekasten G
    Curr Rheumatol Rep; 2015 May; 17(5):34. PubMed ID: 25876754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti-Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies.
    Luchetti MM; Moroncini G; Jose Escamez M; Svegliati Baroni S; Spadoni T; Grieco A; Paolini C; Funaro A; Avvedimento EV; Larcher F; Del Rio M; Gabrielli A
    Arthritis Rheumatol; 2016 Sep; 68(9):2263-73. PubMed ID: 27111463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis.
    Hoffmann-Vold AM; Tennøe AH; Garen T; Midtvedt Ø; Abraityte A; Aaløkken TM; Lund MB; Brunborg C; Aukrust P; Ueland T; Molberg Ø
    Chest; 2016 Aug; 150(2):299-306. PubMed ID: 26997242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis.
    Raschi E; Privitera D; Bodio C; Lonati PA; Borghi MO; Ingegnoli F; Meroni PL; Chighizola CB
    Arthritis Res Ther; 2020 Nov; 22(1):265. PubMed ID: 33168071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
    Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
    Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of skin and lung fibrosis in systemic sclerosis.
    Martinović Kaliterna D; Petrić M
    Expert Rev Clin Immunol; 2019 Nov; 15(11):1215-1223. PubMed ID: 31539483
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional?
    Corallo C; Cheleschi S; Cutolo M; Soldano S; Fioravanti A; Volpi N; Franci D; Nuti R; Giordano N
    Arthritis Res Ther; 2019 Jun; 21(1):152. PubMed ID: 31234888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis.
    Nishijima C; Hayakawa I; Matsushita T; Komura K; Hasegawa M; Takehara K; Sato S
    Clin Exp Immunol; 2004 Nov; 138(2):357-63. PubMed ID: 15498049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.
    Moroncini G; Grieco A; Nacci G; Paolini C; Tonnini C; Pozniak KN; Cuccioloni M; Mozzicafreddo M; Svegliati S; Angeletti M; Kazlauskas A; Avvedimento EV; Funaro A; Gabrielli A
    Arthritis Rheumatol; 2015 Jul; 67(7):1891-903. PubMed ID: 25808833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.